NMNAT Antibodies

Santa Cruz Biotechnology features a diverse variety of NMNAT monoclonal antibodies for investigating nicotinamide adenine dinucleotide (NAD+) metabolism. NMNAT monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Nicotinamide adenine dinucleotide (NAD+) is a crucial coenzyme involved in numerous biological processes, including energy metabolism, DNA repair, and cell signaling. NMNAT (Nicotinamide mononucleotide adenylyltransferase) plays a vital role in the synthesis of NAD+, making it essential for maintaining cellular health and function. Understanding NMNAT dynamics can provide insights into various metabolic disorders and age-related diseases. Researchers can explore NAD+ metabolism pathways using specific molecular tools and techniques. Advanced research methods enable detailed examination of NMNAT's role in cellular processes. Investigating NMNAT function contributes to understanding metabolic regulation and potential therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of NAD+ metabolism and its impact on human health.